Porcine and bovine GH receptor (GHR) cDNAs were stably expressed in mouse L cells, which normally do not possess detectable levels of mouse GHR. Expression of the GHR cDNAs resulted in specific binding of 'SI-labeled GH by these cell lines. To study GHR-related signaling events in these cells, protein tyrosine phosphorylation was examined. In GH-treated cells, a tyrosine-phosphorylated protein with a molecular mass of -95 kDa (pp95) was increased dramatically (-100-fold) relative to non-GH-treated cells. The amount of pp95 within the cells after GH treatment was positively correlated with the number of GHRs on the cells. Tyrosine phosphorylation of pp95 could not be induced by prolactin, insulin, insulin-like growth factor I, interleukin 2, epidermal growth factor, platelet-derived growth factor, or fibroblast growth factor. Phosphorylation of pp95 was found to be a rapid event that could be observed 60 sec after GH treatment. Also, pp95 appears to exist as a complex of two proteins, i.e., pp95 and pp96. The GH-induced response by these cells may be of use in screening GH analogs for biological activity.
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The diversity of GH biological functions has been known for decades. In addition to the studies of GH effects on animal growth and metabolism, a wealth of information concerning GH action has accumulated from in vitro studies using cultured cells. For example, GH treatment of mouse 3T3-F442A preadipocytes can promote differentiation to adipocytes (1) , induce c-fos and c-jun expression (2) , up-regulate vinculin expression (3) , trigger the formation of diacylglycerol (4) , and enhance the metabolic rate of glucose utilization and stimulate the accumulation of lipid (5) . Although several studies have suggested the roles of protein kinase C and guanine nucleotide binding protein(s) in mediating GH signal transduction (6) (7) (8) (9) (10) , the intracellular molecular events after GH binding to its receptor(s) are still poorly understood.
Expression of the cloned GH receptors (GHRs) in cultured cells has enhanced studies of GH-GHR function. For example, introduction of exogenous rat (r) GHR in rat insulinoma RIN-5AH cells and subsequent GH treatment has been shown to increase insulin production by these cells (11) . Expression of rGHR in CHO cells enables them to bind GH and results in a 60% increase in protein synthesis (12) .
It is believed that phosphorylation of receptors as well as cytosolic proteins on serine, threonine, or tyrosine residues plays crucial roles in mediating biological functions of many growth factors and hormones (13, 14) . GHR tyrosine phosphorylation after GH treatment has been demonstrated in several different GH-responsive cell lines (15) (16) (17) . Also, a few qytosolic proteins that include mitogen-activated protein kinase have been shown to be phosphorylated in GH-treated cells (18) (19) (20) (21) . The demonstration that GHR is associated with a tyrosine kinase, JAK2, has greatly enhanced the understanding of initial events after the GH-GHR interaction (22) .
We have cloned (23, 24) the porcine (p) GHR and bovine (b) GHR cDNAs and have generated cell lines that express these GHRs. In this study, the GH-dependent phosphorylation status of proteins from these cell lines was investigated.
MATERIALS AND METHODS Construction of Expression Plasmids. All DNA manipulations were performed using standard techniques (25) . Fulllength pGHR and bGHR cDNA coding sequences were subcloned into a pBR322-derived mammalian expression vector, pMet-bGHc (24, 26) . The resulting plasmids were termed pMet-pGHR and pMet-bGHR and contain the mouse metallothionien I transcriptional regulatory elements and the bGH poly(A) addition signal. For generation of the pGHR truncation mutation plasmid, the pGHR cDNA was assembled into a mammalian expression vector, pMet-IG7, that contains the bacteriophage fl intergenic region (unpublished data). The resulting plasmid was termed pMet-IG-pGHR. Single-stranded pMet-IG-pGHR DNA was isolated as described (27) . By oligonucleotide-directed mutagenesis of pGHR cDNA, a translation stop codon was introduced at position 272 to create a pGHR truncation mutation encoding the entire extracellular and transmembrane domain along with 3 amino acids of the pGHR intracellular domain. The resulting plasmid was termed pGHR-TR2.
Tissue Culture and GHR Stable Cell Lines. Mouse L cells (MLCs) were cultured in Dulbecco's modified Eagle's medium (DMEM) plus 10% (vol/vol) Nu-Serum (Collaborative Research), and gentamicin (GIBCO; 2 uzg/ml) at 370C in a humidified atmosphere containing 5% CO2 in air as described (24) . pMet-pGHR, pMet-bGHR, and pGHR-TR2 DNAs were used to establish stable MLC lines that permanently express the respective GHRs as described (24) . Cell lines that expressed relatively high levels of pGHR mRNA were selected by RNA slot blot analyses and receptor binding ability was determined as described (24) . Three pGHR clones-pGHR-W10, which expresses high levels of pGHR (24) Western Blot Analysis Using an Anti-Phosphotyrosine Antibody. Cell lysates were passed through a 27-gauge needle 10 times to shear genomic DNA. Cell lysates (10 1,u) were mixed with 1 ,ul of 0.6% bromphenol blue and subjected to SDS/ PAGE (29) on 7.5% gels using a Bio-Rad Protean II or Mini-Protean II system (Bio-Rad). After electrophoresis, gels were rinsed twice with blotting buffer [25 mM Tris'HCl/192 mM glycine/20% (vol/vol) methanol/0.075% SDS/0.5 mM sodium orthovanadate] and transferred to a Hybond-ECL membrane (Amersham) for 5 hr at 7 W constant power. Hybond-ECL membrane blots were rinsed twice with rinsing buffer (RB = 10 mM Tris-HCl, pH 7.5/75 mM NaCl/0.1% Tween 20/1 mM EDTA). Blots were incubated overnight in blocking buffer containing 4% (wt/vol) bovine serum albumin (Boehringer Mannheim) in RB and subsequently washed three times with RB. Blots were then incubated for 1 hr with horseradish peroxidase-conjugated anti-phosphotyrosine serum, termed PY20 (ICN; 0.1 pg/ml), in blocking buffer. After incubation, blots were washed three times with RB and developed with an ECL reagent kit by the manufacturer's suggestions (Amersham). Blots were then exposed to x-ray films and developed by standard procedures (Kodak).
RESULTS
Cell Lines that Express pGHR or Truncated pGHR. We have reported (24) that pGHR-W1O cells that express pGHR cDNA are able to bind and internalize 1251-labeled GHs. The mean values for the number of GHRs on the cell lines used in this study were -50,000 for pGHR-W1O cells, 30,000 for pGHR-W7 cells, =150,000 for pGHR-TR2.7 cells, and -30,000 for bGHR-S2 cells (Table 1 ). All receptor numbers were determined using a GH binding assay as described (24) .
Induction of pp95 in MLCs, pGHR-W1O Cells, and Mouse 3T3-F442A Preadipocytes with pGH and a GH Antagonist. To examine intracellular protein phosphorylation after GH treatment of cells that express GHRs, pGH at 1 lg/ml and a GH antagonist, bGH-M8 (30, 31) at 1 ug/ml, were used. DMEMtreated cells served as negative controls. Western blot analysis revealed 15-20 proteins that are tyrosine phosphorylated in all cell lines (Fig. 1) . However, in pGH-treated pGHR-W1O cells, a tyrosine-phosphorylated protein with a molecular mass of -95 kDa (pp95) was found to be increased dramatically (-100 times) when compared with nontreated cells. Importantly, an increase of pp95 was also observed in a native GH-responsive cell line, mouse 3T3-F442A cells. The apparent molecular masses of pp95 in both pGHR-W10 and 3T3-F442A cells were similar except that the increase in pp95 in GH-treated 3T3-F442A cells was much lower. In contrast, no obvious increase of pp95 was observed-in pGH-treated MLCs. Treatment with GH antagonist, bGH-M8, did not elicit any change in the protein-tyrosine phosphorylation pattern in the three cell lines. GH(s) Induce pp95; However, Prolactin (PRL) and Other Hormones and Growth Factors Do Not. To investigate the specificity of pp95 phosphorylation in response to GH treatment, various GHs (human, porcine, bovine, and murine) and rPRL were applied to pGHR-W10 and bGHR-S2 cells. The GHs or rPRL preparations (500 ng/ml) were incubated with the cells for 1 hr. Western blot results are shown as Fig. 2 A and C. All GH treatments were able to induce pp95 at approximately the same level. However, rPRL did not induce pp95. Again, similar results were observed in mouse 3T3-F442A cells (Fig. 2B) . To further establish that pp95 is GH-specific, pGHR-W10 cells were treated with IL-2, EGF, FGF, PDGF, insulin, or IGF-I (Fig. 2D) . No pp95 induction was found in these cells.
Time Course of pp95 Induction in pGHR-W10 Cells. pGHR-W10 cells were grown to confluence and GH was depleted from the culture medium as described above. Cells were then treated with pGH at 500 ng/ml for 0.5, 1, 2.5, 5, 10, 30, 60, 120, and 360 min at 370C. The results are shown in Fig. 3 . Induction ofpp95 could be detected as early as 1 min after GH treatment and became quite evident at 5 min. Levels of pp95 reached a maximum at 10 min and were maintained through 30 min. Levels of pp95 began to decline at 60 min to a final level that was l10o of maximal induction. In contrast, the tyrosine phosphorylation status of other proteins remained constant throughout the 3-hr time interval. Similar results Fig. 4 . Induction of pp95 could be detected at OH concentrations as low as 5 ng/ml (=zO.2 nM).
The pp9S signal became quite obvious at a GH concentration of 250 ng (-10 nM) and reached the maximum at 500 ng/ml (20 nM 5 . Pulse-chase-pulse experiment of GH-induced pp95 in pGHR-W10 cells. pGHR-W10 cells were treated with pGH (500 ng/ml) or without pGH for 10 min and then pGH was removed. Cells were lysed at different times after GH withdrawal (lanes 0-60). Sixty minutes after GH withdrawal, the cells were treated (second pulse) again with pGH (500 ng/ml) for 10 min (lane +pGH). All cell extracts were analyzed. Arrowhead, pp95.
samples were resolved using Bio-Rad Protean II system ti6 x 20 cm) instead of Mini-Protean 11 (8 x 7.3 cm) . The Fe~ults are shown in Fig. 7 . pp95 appears as two bands with molecular masses of 96 kDa and -95 kDa. In time-course and GH dose-response studies, pp96 and pp95 induction showed no significant differences (data not shown). We refer to the pp95/pp96 doublet as pp95.
DISCUSSION
Tyrosine, serine, and threonine kinas~s play key roles in transducing intracellular signals from various types of hormones and growth factors (32, 33) . A number of substrates or mediator proteins of receptor tyrosine kinases have been identified and their function has been characterized in the signal transduction process (34) .
It has been reported that MLCs, the parental cells of pGHR-W10 and bGHR-S2, have no or few GHRs (17, 24) . Expression of GHR cDNAs enables MLCs to bind GH, which causes a dramatic increase of pp95 induction wherdias other tyrosine phosphorylated proteins remain unchanged. This result suggests that GH-induced pp95 is correlated with the appearance of GHRs on MLCs. Importantly, a similar response was observed in mouse 3T3-F442A cells, which have been shown to be GH responsive. This result suggests that pp95 exists in cells that normally respond to GH and may play a role in the GH signal transduction. Inability of a GH antagonist, bGH-M8, to induce pp95 and the lack of pp95 induction observed in GH-treated MLCs that express a truncated form of pGHR strongly support the involvement of a GH-GHR interaction with pp95 induction. Furthermore, our results revealed that only GHs, and not PRL or other growth factors and hormones, are able to elicit the pp95 response. Also, induction of pp95 in MLCs that express p- either pGHR or bGHR indicates that GH-induced pp95 is GHR-dependent.
It is unlikely that pp95 is the GHR since the molecular mass of GHR has been reported to be 4120 kDa in both MLCs (24) and mouse 3T3-F442A preadipocytes (15) . Western blot analysis has revealtd that pp95 is not recognized by antiserum against the rGHR intracellular domain (data not shown). Moreover, an excess of phosphotyrosine during the Western blot procedure specifically reduced the GH-dependent pp95 signal (data not shown), indicating that pp95 is in fact phosphorylated on tyrosine residues.
Induction of pp95 was not observed in insulin-or IGF-Itreated cells. However, both insulin and IGF-I treatment of MLCs or pGHR-W10 cells did result in induction ofa protein molecule with a molecular mass of p150 kDa (Fig. 2D) . This indicates that MLCs probably possess receptors for both iisulin and IGF-I. It also has been demonstrated that MLCs possess receptors for FGF and PDGF, since treatment of MLCs with these growth factor can induce tyrosine phosphorylation of ERK2 proteins (mitogen-activated protein kinases) (P. Harding and J.J.K., unpublished data). However, pp95 induction was not observed in cells treated with these growth factors. Thus, these results strongly suggest that pp95 induction is a GH-specific event.
Phosphorylation and dephosphorylation of proteins are typical of intracellular signal mediators. It has been reported (19, 35) that GH induces mitogen-activated protein kinases and p90 S6 kinase and that their induction levels are maximum after 10-15 min of GH treatment. Our pp95 time dependency results agree with these observations. We examined the possibility that pp95 and p90 S6 kinase are identical by Western blot analysis using anti-rsk (p90 S6 kinase) serum (Upstate Biotechnology). The results did not show cross reactivity with pp95 and suggest that pp95 and S6 kinase are not the same molecules (data not shown).
The observation of doublet bands in the GH induction experiments suggests that GH-induced pp95 is composed of more than one molecule. The subtle molecular mass difference between pp95 and pp96 may result from different levels of protein phosphorylation or other posttranslational modifications of the same protein, or they may be distinct protein molecules. However, tyrosine phosphorylation of both proteins is GH-dependent and specific despite the difference in size.
GHRs along with PRL receptors and cytokine receptors belong to the same family (36) . One common characteristic reported among these receptors is that they lack intrinsic tyrosine kinase activity. However, it has been demonstrated that several receptors in this family do possess kinase activ-ity. For example, the IL-2 receptor 83 subunit can tightly associate with p56lck (a src-family tyrosine kinase) through an SH2 domain (37) . Garcia et al. (38) have characterized a tyrosine kinase activity associated with the high-affinity IL-2 receptor complex that possesses'a molecular mass of 97 kDa.
It is possible that the 97-kDa protein could be pp95. Recently, the existence of tyrosine kinase activity has been shown in PRL-treated rat lymphoma Nb2 cells, and several proteins, including a protein with a molecular mass of =90 kDa, were tyrosine-phosphorylated (39) . As mentioned earlier, GHRs expressed in cultured cells have been shown to be phosphorylated, apparently by a tyrosine kinase activity (JAK 2) found in these cells, including MLCs (17) . It is reasonable to deduce that the pp95 tyrosine phosphorylation depends on the GHRassociated tyrosine kinase (22) .
In our experimental system, a positive correlation exists between the number ofGHRs and the level ofpp95 induction. Cell lines that express higher levels of GHRs have elevated levels of GH-induced pp95. However, this result contradicts those of others (17) , in which GHR tyrosine phosphorylation was found to be independent of GHR number but dependent on the amount of tyrogine kinase within the cells. These results may be explained by the difference between the GH-induced GHR self-phosphorylation and the GHRassociated tyrosine kinase target protein phosphorylation. Overexpression of GHRs in MLCs may maximize the ability of tyrosine kinases to phosphorylate its substrate(s). However, GHR was not observed in Western blot analysis using anti-phosphotyrosine (PY20). We found that this is due to the specificity of PY20. When an anti-phosphotyrosine antibody from a different source (G410 from Upstate Biotechnology) was employed in the Western blot analysis, a protein with a molecular mass of -120 kDa was observed in GH-treated pGHR-W10 cells (data not shown). This protein molecule, presumably, represents the tyrosine-phosphorylated GHR. Molecular identification of pp95 and its gene are required to distinguish it from other tyrosine-phosphorylated proteins that have the same approximate molecular mass.
The ability to activate tyrosine phosphorylation of target proteins specifically in response to the GH-GHR interaction has important implications for determining domains, motifs, or amino acids within the intracellular portion of the GHR sequence required for signal transduction. In this regard, GHR analogs that possess amino acid substitutions or deletions within their extracellular or intracellular region can be quickly analyzed for their ability to respond to GH and elicit a pp95 response. In addition, the ability of GHR-containing MLCs to respond specifically and quickly to GH allows the efficient screening of GH analogs for their ability to elicit or suppress the pp95 response. Thus, this cellular-based GHresponsive assay system is useful as a rapid screen for the activity of GH analogs, GH muteins, and GH "biomimotopes" (compounds that mimic the proposed biological effect) which, hopefully, will result in the discovery of more potent GH agonists and antagonists.
